
Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
Rinku A. Patel, PharmD, RPh, founder and CEO at KloudScipt, discusses effective integration of technology in the pharmacy setting.
Rinku A. Patel, PharmD, RPh, founder and CEO at KloudScipt, discusses effective integration of technology in the pharmacy setting.


